Scientific Poster Session I - Students Research-in-Progress

Students Research in Progress
  Saturday, October 12, 2024
  11:30 AM–01:00 PM

Abstract

Introduction: As one of the most significant public health concerns, community-acquired pneumonia (CAP) requires precise and effective management. In order to optimize therapeutic approaches, this study explores the potential impact of post-prescription review intervention. Since clinical pharmacists play an increasingly important role in healthcare, specifically in infectious diseases, our study will evaluate the influence of their integration into the multidisciplinary team and antimicrobial stewardship program on therapeutic appropriateness.

Research Question or Hypothesis: The primary objective of this study is to assess the impact of post-prescription review intervention on therapeutic appropriateness in the management of CAP.

Study Design: A single-center quasi-experimental design will be implemented.

Methods: Participants will be divided into a pre-phase group (receiving standard care without ID clinical pharmacist) and post-phase group (benefiting from ID clinical pharmacist expertise). ID clinical pharmacists will be integrated into the healthcare team, actively participating in post-prescription reviews and contributing to antimicrobial stewardship efforts. Data will be collected retrospectively, and outcomes will be compared between the two groups using appropriate statistical analyses.

Results: Within the post-phase group, therapeutic appropriateness is expected to improve significantly. We expect higher rates of adherence to treatment guidelines, increased medication appropriateness, a potential reduction in hospital LOS, lower 30-day all-cause or pneumonia readmission rates, and a decrease in in-hospital mortality. These findings would emphasize the positive impact of ID clinical pharmacist-led interventions on CAP management.

Conclusion: There are several implications from the expected promising results of this study. It first underlines the critical role of pharmacy professionals in ensuring therapeutic appropriateness, especially those who specialize in Infectious Diseases. The findings can be used to inform healthcare policy and recommend the integration of clinical pharmacists in multidisciplinary teams dealing with infectious diseases.

Presenting Author

Sahar Elnajjar Ph.D
University Sains Malaysia

Authors